DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be ...

Medtech company Baxter International unveiled the name and logo of its proposed kidney care and acute therapies company this week. Baxter announced the spinoff will be called Vantive, adding that the ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and ...

Baxter has settled on a name for its $4.5 billion kidney care division, which is slated to strike out on its own as an independent portfolio of dialysis machines, acute renal therapies and services.

In February, Baxter completed the sale of Vantive, its kidney care business, to The Carlyle Group. The move created a new kind of freedom for Vantive. The company had strong ties to the past and ...

The Vantive mission, Extending Lives, Expanding Possibilities, will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and beyond.